MONUROL

This brand name is authorized in Canada, Ecuador, Spain, Hong Kong, Israel, Singapore, Turkey, United States

Active ingredients

The drug MONUROL contains one active pharmaceutical ingredient (API):

1 Fosfomycin UNII 7FXW6U30GY - FOSFOMYCIN TROMETHAMINE

Fosfomycin exerts a bactericidal effect on proliferating pathogens by preventing the enzymatic synthesis of the bacterial cell wall. Fosfomycin inhibits the first stage of intracellular bacterial cell wall synthesis by blocking peptidoglycan synthesis. Read about Fosfomycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MONUROL Granules for oral solution	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01XX01	Fosfomycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02240335
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1293-MEE-0815
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 76799
Country: HK	Department of Health Drug Office	Identifier(s): 43159
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3611
Country: SG	Health Sciences Authority	Identifier(s): 11013P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699569240266
Country: US	FDA, National Drug Code	Identifier(s): 0456-4300